Avita Medical
RCEL
62 hedge funds and large institutions have $89.6M invested in Avita Medical in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 14 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.5% less ownership
Funds ownership: 33.45% → 29.95% (-3.5%)
10% less funds holding
Funds holding: 69 → 62 (-7)
40% less capital invested
Capital invested by funds: $148M → $89.6M (-$58.5M)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$1.08M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$808K |
| 3 |
State Street
Boston,
Massachusetts
|
+$764K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$321K |
| 5 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$316K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$10.3M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$4.47M |
| 3 |
RI
RTW Investments
New York
|
-$2.64M |
| 4 |
MA
MCF Advisors
Covington,
Kentucky
|
-$652K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$546K |
RCEL Hedge Fund Activity: Q4 2021 in Review
62 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2021, worth a combined $89.6M — down 40% from $148M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of RCEL and 7 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 22 added.
The largest buyer was Goldman Sachs, adding an estimated $1.08M. The largest seller was Redmile Group, cutting an estimated $10.3M.
- 62 institutional investors held Avita Medical (RCEL) as of Q4 2021, down from 69 in Q3 2021.
- Funds reported $89.6M of Avita Medical stock for Q4 2021, down 40% quarter-over-quarter.
- 7 funds opened new Avita Medical positions in Q4 2021 and 14 closed out, a net change of -7 holders.
- The largest Avita Medical buyer in Q4 2021 was Goldman Sachs, an estimated $1.08M added.
- The largest Avita Medical seller in Q4 2021 was Redmile Group, an estimated $10.3M sold.
Based on aggregated 13F filings for Q4 2021.